Bioactive peptide inhibiting aminopeptidase M Leuhistin (Hydrochloride)

Leuhistin is a bioactive natural peptide isolated from culture filtrate of Bacillus laterosporus. The peptide competitively inhibited aminopeptidase M (AP-M, AP-N, and CD13).¹⁾ Therefore, this peptide is considered to be a useful tool for biochemical, cell biological, and pharmacological studies.
* This product is for research use only.
* Please do not hesitate to contact Funakoshi if you need a Structure Data Format (SDF) file and/or bulk quantity of the compound.

Structure of leuhistin (#18718)

Aminopeptidase M (EC 3.4.11.2) which is also know as AP-M, membrane alanyl aminopeptidase, and microsome aminopeptidase, was initially isolated from microsome membrane fractions prepared from porcine kidney by Pfleiderer and Celliers.²⁾ In 1980, it was proposed that the name of the enzyme should be changed to aminopeptidase N (AP-N) because of its enzymatic preference to neutral amino acid residues.³⁾ Then, the new name of the enzyme is widely used these days.⁴⁾
It has also been clarified that AP-M (AP-N) is actually the same protein of CD13 which expresses the cell surface of bone marrow progenitor cells, monocytes, and granulocytes.⁵⁾
Molecular weight of AP-M (AP-N, CD13) is 110 KDa and the enzyme is a metalloprotease 2 which belongs to peptidase family M1. AP-M has different isozymes and is a universal enzyme existing in a variety of organs, tissues, and cell types such as endothelial cells, epithelial cells, fibroblasts, and leukocytes. It is also known that the enzyme relates tumor formulation, immune functions, and pain sensations, and functions as a virus receptor to corona virus and other human viruses. In addition to the expression of the variety of functions, AP-M relates antigen trimming and antigen presentation.
The multiple functions of AP-M facilitate regulation of functional peptide-mediated response such as pain sensation and vasopressin secretion and affect several important biological process such as immune function, cell growth, secretion, infiltration, angiogenesis. Therefore, the development of new therapies targeting AP-M is of interest.⁶⁾

■ Inhibitory activity of leuhistin against various aminopeptidases (Cited from Ref. 1)

*Biological activity of the product was not verified. The values shown above were cited from the references.